POLE and endometrial cancer: The mutational landscape, CNA profile, absence of POLE exonuclease domain mutation, and MSI-high status demonstrate that HCI-EC-23 is an MSI hypermutated cell line according to the molecular classification identified in the TCGA analysis5 of endometrial cancer.